stock-detail (CLVS)

Oncology Corporate Profile

Company Description

This company does not have any commercial products

This company does not have any pipeline products

Recent News Headlines

4/24/2017 06:17 pm

4/24/2017 06:17 pm

4/24/2017 06:17 pm

4/24/2017 06:17 pm

4/21/2017 06:17 am

4/21/2017 06:17 am

4/21/2017 06:17 am

4/21/2017 12:17 am

4/21/2017 12:17 am

4/21/2017 12:17 am

4/21/2017 12:17 am

4/21/2017 12:17 am

4/20/2017 12:17 pm

4/20/2017 06:17 am

4/10/2017 06:17 am

4/10/2017 06:17 am

4/10/2017 06:17 am

4/7/2017 12:17 pm

[$$] Overheard

3/29/2017 04:01 am

Clovis Oncology Announces Data Presentations at AACR Annual Meeting 2017

3/28/2017 08:03 pm

[Business Wire] - Clovis Oncology, Inc. today announced that rucaparib preclinical data will be presented at the American Association for Cancer Research Annual Meeting 2017. AACR will take place April 1-5, 2017 in Washington, DC.

SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of the Board of Directors of Clovis Oncology, Inc. - CLVS

3/24/2017 10:03 pm

[Accesswire] - BALA CYNWYD, PA / ACCESSWIRE / March 24, 2017 / The law Office of Brodsky & Smith, LLC announces an investigation of the Board of Directors of Clovis Oncology, Inc. ("Clovis" or the "Company") ...